Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Esbjerg – page 9

103 clinical trials in Esbjerg, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Esbjerg at a glance
103
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

103 trials in Esbjerg

Open in trial search

Study on Reducing Inhaled Corticosteroids and Using Azithromycin for Patients with Severe COPD

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Azithromycin
  • Sponsor:Frederiksberg Hospital

Cardiac arrest

Not recruiting

Study on Sodium Bicarbonate and Sodium Chloride for Patients with In-Hospital Cardiac Arrest

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Region Midtjylland

Study on the Safety and Effects of AZD4831 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) with Fibrosis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:AZD4831
  • Sponsor:AstraZeneca AB

Study Comparing Dupilumab and Mepolizumab for Treating Chronic Rhinosinusitis with Nasal Polyps in Danish Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Rigshospitalet

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Merck Sharp & Dohme LLC
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Novartis Pharma AG

Multiple sclerosis

Not recruiting

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Colestyramine
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Esbjerg

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking studies focusing on heart failure prevention and innovative treatments for cardiovascular diseases. Research includes evaluation of new drug combinations and therapies for reducing major cardiac events.

  • Heart Failure Prevention
  • NSTEMI Treatment Strategies
  • Cardiovascular Risk Management

Novel approaches in treating various cardiac conditions with emphasis on preventive care and therapeutic innovations.

02 Autoimmune Disorders

Clinical investigations into multiple sclerosis and inflammatory conditions, including studies of new biological therapies and treatment optimization for chronic conditions.

  • Multiple Sclerosis Treatments
  • Psoriatic Arthritis Management
  • Chronic Rhinosinusitis

Comprehensive research focusing on improving patient outcomes through targeted therapies.

03 Metabolic Health

Studies addressing obesity management and metabolic disorders, with innovative approaches to weight reduction and metabolic health improvement.

  • Weight Management Therapies
  • Diabetes Complications
  • Metabolic Disease Treatment

Advanced therapeutic strategies combining medication with lifestyle interventions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.